Structural Basis for Long Residence Time c-Src Antagonist: Insights from Molecular Dynamics Simulations

被引:1
作者
Zhong, Haiyang [1 ,2 ]
Zhang, Zhengshuo [1 ]
Chen, Mengdan [1 ]
Chen, Yue [1 ]
Yang, Can [1 ]
Xue, Yunsheng [1 ]
Xu, Pei [1 ]
Liu, Hongli [1 ]
机构
[1] Xuzhou Med Univ, Jiangsu Key Lab New Drug Res & Clin Pharm, 209 Tongshan Rd, Xuzhou 221004, Peoples R China
[2] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310058, Peoples R China
基金
中国国家自然科学基金;
关键词
molecular dynamics simulations; c-Src; dissociation; residence time; GROWTH-FACTOR RECEPTOR; KINASE; INHIBITORS; BINDING; OPTIMIZATION; MECHANISM; CANCER; CONFORMATION; SELECTIVITY; ACTIVATION;
D O I
10.3390/ijms251910477
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
c-Src is involved in multiple signaling pathways and serves as a critical target in various cancers. Growing evidence suggests that prolonging a drug's residence time (RT) can enhance its efficacy and selectivity. Thus, the development of c-Src antagonists with longer residence time could potentially improve therapeutic outcomes. In this study, we employed molecular dynamics simulations to explore the binding modes and dissociation processes of c-Src with antagonists characterized by either long or short RTs. Our results reveal that the long RT compound DAS-DFGO-I (DFGO) occupies an allosteric site, forming hydrogen bonds with residues E310 and D404 and engaging in hydrophobic interactions with residues such as L322 and V377. These interactions significantly contribute to the long RT of DFGO. However, the hydrogen bonds between the amide group of DFGO and residues E310 and D404 are unstable. Substituting the amide group with a sulfonamide yielded a new compound, DFOGS, which exhibited more stable hydrogen bonds with E310 and D404, thereby increasing its binding stability with c-Src. These results provide theoretical guidance for the rational design of long residence time c-Src inhibitors to improve selectivity and efficacy.
引用
收藏
页数:13
相关论文
共 56 条
  • [1] Type II Inhibitors Targeting CDK2
    Alexander, Leila T.
    Moebitz, Henrik
    Drueckes, Peter
    Savitsky, Pavel
    Fedorov, Oleg
    Elkins, Jonathan M.
    Deane, Charlotte M.
    Cowan-Jacob, Sandra W.
    Knapp, Stefan
    [J]. ACS CHEMICAL BIOLOGY, 2015, 10 (09) : 2116 - 2125
  • [2] Uncovering Nonconventional and Conventional Hydrogen Bonds in Oligosaccharides through NMR Experiments and Molecular Modeling: Application to Sialyl Lewis-X
    Battistel, Marcos D.
    Azurmendi, Hugo F.
    Frank, Martin
    Freedberg, Daron I.
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2015, 137 (42) : 13444 - 13447
  • [3] A WELL-BEHAVED ELECTROSTATIC POTENTIAL BASED METHOD USING CHARGE RESTRAINTS FOR DERIVING ATOMIC CHARGES - THE RESP MODEL
    BAYLY, CI
    CIEPLAK, P
    CORNELL, WD
    KOLLMAN, PA
    [J]. JOURNAL OF PHYSICAL CHEMISTRY, 1993, 97 (40) : 10269 - 10280
  • [4] Belsches A P, 1997, Front Biosci, V2, pd501
  • [5] Structure-kinetic relationship reveals the mechanism of selectivity of FAK inhibitors over PYK2
    Berger, Benedict-Tilman
    Amaral, Marta
    Kokh, Daria B.
    Nunes-Alves, Ariane
    Musil, Djordje
    Heinrich, Timo
    Schroeder, Martin
    Neil, Rebecca
    Wang, Jing
    Navratilova, Iva
    Bomke, Joerg
    Elkins, Jonathan M.
    Mueller, Susanne
    Frech, Matthias
    Wade, Rebecca C.
    Knapp, Stefan
    [J]. CELL CHEMICAL BIOLOGY, 2021, 28 (05): : 686 - +
  • [6] Tyrosine kinase signalling in breast cancer - Epidermal growth factor receptor and c-Src interactions in breast cancer
    Biscardi, JS
    Ishizawar, RC
    Silva, CM
    Parsons, SJ
    [J]. BREAST CANCER RESEARCH, 2000, 2 (03): : 203 - 210
  • [7] A Medicinal Chemist's Guide to Molecular Interactions
    Bissantz, Caterina
    Kuhn, Bernd
    Stahl, Martin
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (14) : 5061 - 5084
  • [8] Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity
    Boschelli, DH
    Ye, F
    Wang, YD
    Dutia, M
    Johnson, SL
    Wu, BQ
    Miller, K
    Powell, DW
    Yaczko, D
    Young, M
    Tischler, M
    Arndt, K
    Discafani, C
    Etienne, C
    Gibbons, J
    Grod, J
    Lucas, J
    Weber, JM
    Boschelli, F
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (23) : 3965 - 3977
  • [9] Benzodiazepine Derivatives as Potent Vasopressin V2 Receptor Antagonists for the Treatment of Autosomal Dominant Kidney Disease
    Cao, Xudong
    Wang, Peng
    Yuan, Haoxing
    Zhang, Haoran
    He, Yan
    Fu, Kequan
    Fang, Qian
    Liu, Hongli
    Su, Limin
    Yin, Long
    Xu, Pei
    Xie, Yuyang
    Xiong, Xiaochun
    Wang, Junqi
    Zhu, Xu
    Guo, Dong
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2022, : 9295 - 9311
  • [10] Case DA., 2022, AMBER 2020